A double-blind, placebo-controlled phase Ila study investigating CYT003-QbG10 as a novel immunotherapy in patients suffering from house dust mite allergy de réir Kuendig, T, Pichler, C, Scherer, K, Bircher, A, Mueller, P, Ulrich, M, Bachmann, M, Renner, W, Senti, G

Putting appraisal in context de réir Parkinson, B

Rannpháirtithe: “…Scherer, K…”